|Other Names||Fc receptor-like protein 1, FcR-like protein 1, FcRL1, Fc receptor homolog 1, FcRH1, IFGP family protein 1, hIFGP1, Immune receptor translocation-associated protein 5, CD307a, FCRL1, FCRH1, IFGP1, IRTA5|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Synonyms||FCRH1, IFGP1, IRTA5|
|Function||May function as an activating coreceptor in B-cells. May function in B-cells activation and differentiation.|
|Cellular Location||Cell membrane; Single-pass type I membrane protein|
|Tissue Location||Primarily expressed in secondary lymphoid tissues by mature subsets of B-cells. Detected in spleen, lymph node, heart, skeletal muscle, kidney, liver and placenta Specifically expressed by mature B lineage cells with higher expression in naive versus memory B-cells (at protein level)|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a member of the immunoglobulin receptorsuperfamily and is one of several Fc receptor-like glycoproteinsclustered on the long arm of chromosome 1. The encoded proteincontains three extracellular C2-like immunoglobulin domains, atransmembrane domain and a cytoplasmic domain with twoimmunoreceptor-tyrosine activation motifs. This protein may play arole in the regulation of cancer cell growth. Alternative splicingresults in multiple transcript variants.
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Davila, S., et al. Genes Immun. 11(3):232-238(2010)Kazemi, T., et al. Cancer Immunol. Immunother. 58(6):989-996(2009)Kazemi, T., et al. Int. J. Cancer 123(9):2113-2119(2008)Du, X., et al. Blood 111(1):338-343(2008)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.